ICAD Nasdaq

icad inc.

ICAD | $1.52 -1.3% -4.76% 190K

(0.0% 1d) (-1.9% 1m) (4.8% 1y) (0.0% 2d) (0.0% 3d) (-2.6% 7d) (182.35% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 40,340,846
http://www.icadmed.com
Sec Filling | Patents | 138 employees

iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment include image analysis and workflow products. The Cancer Therapy segment consists radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.

cancer radiation therapy

add to watch list Paper trade email alert is off

Press-releases

iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| -11.63% | O: 1.74% H: 0.0% C: -2.86%
symposium

iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
Published: 2024-04-09 (Crawled : 12:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| -3.8% | O: 5.7% H: 11.98% C: 7.78%
precision breast health cancer risk solutions for

iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
Published: 2024-04-08 (Crawled : 21:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| -3.8% | O: 5.7% H: 11.98% C: 7.78%
disease risk meeting heart cardiology

iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)
Published: 2024-04-03 (Crawled : 12:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| -5.0% | O: 1.25% H: 18.52% C: 17.28%
breast cancer

iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| -1.3% | O: -4.55% H: 8.84% C: 8.84%
breast solutions enabling

iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists
Published: 2024-03-19 (Crawled : 13:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| 2.01% | O: 0.0% H: 3.36% C: 1.34%

iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-03-12 (Crawled : 20:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| -12.14% | O: 4.05% H: 2.78% C: 0.0%
financial results

iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| -3.18% | O: -0.64% H: 22.76% C: 12.82%
breast cancer platform

iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)
Published: 2024-02-27 (Crawled : 14:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| -2.56% | O: 1.92% H: 0.63% C: -1.26%

iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
ICAD | $1.52 -1.3% -4.76% 190K

Technology Services

| -2.56% | O: 1.92% H: 0.63% C: -1.26%
report year financial results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001193805-24-000099	4	2024-01-26	2024-01-23	Buy	A	40000	40000
0001193805-24-000020	4	2024-01-05	2024-01-03	Buy	A	25000	25000
0001193805-24-000019	4	2024-01-05	2024-01-03	Buy	A	30000	30000
0001193805-24-000018	4	2024-01-05	2023-12-26	Buy	A	50000	50000